The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Ya-ling Han
Showing 1-12 of 12 articles
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis
Wang M,
Song G,
Chen M,
Feng Y,
Wang J,
Liu X,
Zhou S,
Fang Z,
Han Y,
Xu K,
Yu B,
Xu B,
Yang Y,
Piazza N,
Wu Y,
Gao R
January 28, 2022 | 10.4244/EIJ-D-21-00040
Biodegradable polymer-coated versus durable polymer-coated sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial
Xu K,
Xu B,
Guan C,
Jing Q,
Zheng Q,
Li X,
Zhao X,
Wang H,
Zhao X,
Li Y,
Li J,
Yang Y,
Han Y
April 2, 2021 | 10.4244/EIJ-D-19-00865
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
Xu B,
Yang Y,
Han Y,
Huo Y,
Wang L,
Qi X,
Li J,
Chen Y,
Kuo H-C,
Ying S,
Cheong W-F,
Zhang Y,
Su X,
Popma J,
Gao R,
Stone G
August 3, 2018 | 10.4244/EIJ-D-17-00796
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y,
Liu H,
Yang Y,
Zhang J,
Xu K,
Fu G,
Su X,
Jiang T,
Pang W,
Chen J,
Yuan Z,
Li H,
Wang H,
Hong T,
Liu H,
Sun F,
Allocco DJ,
Zhang M,
Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial
Zhang Y-J,
Wang X-Z,
Fu G,
Jing Q,
Wang G,
Jin C-Y,
Xie L,
Cai J-Z,
Xu B,
Han Y
November 20, 2016 | 10.4244/EIJV12I10A209
Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study
Xu B,
Yang Y,
Han Y,
Lu S-Z,
Li B,
Liu Q,
Zhu G-Y,
Cui J-Y,
Li L,
Zhao Y-L,
Kirtane AJ
May 20, 2014 | 10.4244/EIJV10I1A12
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
Yu X-Y,
Chen J,
Zheng Z-W,
Wu H,
Li L-W,
Zhang Z-W,
Chen Z-H,
Lin Q-X,
Han Y,
Zhong S-L
September 27, 2013 | 10.4244/EIJV9I5A90
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation
Liang Z-Y,
Han Y,
Zhang X-L,
Li Y,
Yan C-H,
Kang J
July 26, 2013 | 10.4244/EIJV9I3A53
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial
Gao R,
Xu B,
Lansky AJ,
Yang Y,
Ma C,
Han Y,
Chen S,
Li H,
Zhang R,
Fu G,
Yuan Z,
Jiang H,
Huo Y,
Li W,
Zhang Y-J,
Leon MB
May 21, 2013 | 10.4244/EIJV9I1A12
Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study
Zhu X-Y,
Qin Y,
Han Y,
Zhang D-Z,
Wang P,
Liu Y-F,
Xu Y,
Jing Q,
Xu K,
Gersh B,
Wang X-Z
March 22, 2013 | 10.4244/EIJV8I11A195
A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study
Han Y,
Zhang L,
Yang L-X,
Liu H-L,
Qu P,
Li W-M,
Jiang T,
Li S-M,
Jing Q,
Zhang Q-Y,
Xu B,
Li Y,
Gao R
November 20, 2012 | 10.4244/EIJV8I7A124
1
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023